Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Bid in for $0.05

<< Previous

Bullboard Posts

Next >>

Comment by NoamGottesmansson Oct 06, 2018 2:05pm

121 Views

Post# 28757736

RE:Bid in for $0.05

Ha! Haha Never the action will go down to 0.05¢ because there is support at 0.09¢ and nobody wants to sell at the bottom of this price. You will see next week a big news will come out here and you will not be able to buy shares because it will go up too fast.

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs